The present invention relates to a liquid handling system for handling a liquid sample. More particularly, the present invention relates to a liquid handling system for crystallization of macromolecules, such as proteins.
The understanding of specific properties, functions and three-dimensional structure of proteins is an invaluable asset for understanding protein-ligand interaction and rational drug design. From the basic biochemical standpoint, for example, information on the three-dimensional structure of protein or the like is the basis to understand the functional role of molecules in a biochemical system.
In analyzing the structure of proteins, it is generally desirable to grow X-ray diffraction quality crystals from small quantities of a biomolecule. However, structural analysis of protein is currently a labor-intensive, lengthy process that requires significant consumption of expensive macromolecules and reagents. With the advent of robust expression and protein purification systems, high intensity, synchrotron x-ray sources and computer based methods of solving diffraction patterns, a rate limiting step in structural studies lies in rapidly growing x-ray quality crystals from small quantities of biomolecule.
The present invention provides for methods and hardware for growing crystals of biological macromolecules using real-time, or dynamic, control of parameters that promote crystal growth from protein solution. Many prior crystallization devices available for high throughput screening of crystallization conditions are incapable of addressing crystallographers' requirements for an efficient crystallization system. The present invention provides a fluid sample handling system comprising two microfabricated interacting pins for forming and handling droplets of a biomolecule solution and forming crystals of the biomolecule. The pins are spaced a predetermined distance from each other at their tips to define a sample acquisition region. The pins acquire and hold a droplet of the biomolecule solution in the sample acquisition region formed in the space between the tips and concentrate the biomolecule solution to promote crystal growth.
The present invention provides a system and methods for growing crystals of biological macromolecules using real-time, or dynamic, control of parameters that promote crystal growth from the protein solution. The crystallization system of the present invention is capable of forming a high resolution quality crystal using between about one and about ten nanograms of a biomolecule, such as protein. The present invention provides an automated system that may test up to 1000 conditions per day using only 5 –50 micro-grams of the target biomolecule. Each test can be monitored in real-time for successful crystal formation, resulting in fine adaptive control of the automation system. Each successfully formed crystal may be frozen in place, which is also appropriate for taking the crystal directly to diffraction studies.
a illustrates a microfabricated fluid handling system employing a pin assembly according to the teachings of the present invention.
b illustrates a tip region of the fluid handling system of
a and 2b illustrate the operation of the fluid handling system in a sample acquisition mode according to the teachings of the present invention.
a and 4b illustrate the fluid handling system of
a–7h are detailed views of the tip region of an exemplary pin assembly of the invention, illustrating different pin tip shapes.
The present invention provides a fluid handling system for handling a predetermined volume of a fluid, such as a liquid sample. The system of the present invention provides for precision handling of a liquid sample by a fluid handling system using two interacting pins. The fluid handling system is suitable for use in a basic research or a commercial environment to promote biomolecule crystallization. The invention will be described below relative to an illustrative embodiment. Those skilled in the art will appreciate that the present invention may be implemented in a number of different applications and embodiments and is not specifically limited in its application to the particular embodiment depicted herein.
As used herein, the term “handling” is intended to include manipulating, retrieving, dispensing, acquiring or delivering a fluid, or any other suitable means for conveying the fluid.
As used herein, the term fluid is intended to include any type of liquid or gas, including, for example, a biological, biochemical or chemical sample, analyte, reagent, precursor for synthesis, or buffer. The fluidcan ne employed during use with a microfluidic system.
As used herein, the terms “protein solution” or “biomolecule solution” includes a solution comprising a molecule to be crystallized, e.g. protein or biomolecule.
The term “protein” is exemplary and it is understood that the present invention can be used to crystallize materials susceptible or capable of being crystallized under the conditions described herein. For example, molecules that can be used with the present invention include proteins, nucleic acids, e.g., DNA or RNA, co-factors, substrates, substrate analogs, or derivatives of any of these molecules. Further, the present invention is intended to be used with fragments of biomolecules, e.g. peptides or nucleic acid fragments. The present invention is also intended to be used with modified, e.g., in vivo or in vitro, macromolecules. For example, protein molecules can be modified in vivo, e.g., glycosylated, myristolated, or adenylated. Alternatively, protein molecules may be modified in vitro, e.g., chemically modified. The present invention is also intended to be used in co-crystallization or crystallization of complexes of any of the biomolecule types above.
The terms “effector” or “effectors” represent all the possible solutes or components or conditions of a buffer that might be set as the conditions to promote crystallization. The terms include, but are not limited to, ions, pH, temperature, detergents, and other molecules and components known to those skilled in the art of biomolecule crystallization.
The term “transpiration” as used herein refers to the exchange of fluid between a sample and the environment, including the process of evaporation.
The term “integration ratio” means the ratio of protein incorporated into the crystal as compared to the total amount of protein consumed in attempting to grow a crystal. In a major improvement over other crystallization techniques, the present method allows crystal growth from small amounts of purified macromolecule. The crystals resulting from this new method are comparable in size to crystals grown by other techniques, despite using approximately two orders of magnitude less starting material. In one embodiment the integration ratio of polypeptide in the crystal as compared to total protein used to grow the crystal is 1:50, 1:100, 1:150, 1:200, 1:250, 1:300, 1:400, 1:500, 1:750,1:1000, 1:1500, 1:2000, 1:2500, 1:3000, 1:4000, 1:5000, 1:6000, 1:7500, 1:10,000, 1:20,000, 1:30,000, 1:40,000, 1:50,000. It should be understood that any of the above ratios can be the beginning or end point for a range of ratios over which the instant invention is intended cover.
The term “static crystallization condition” is defined wherein the various parameters that effect crystallization are varied by mixing macromolecules with different effectors including buffers, precipitating agents, additives, ligands and, substrates.
In conventional crystallization experiments static conditions are set and the solution conditions are then allowed to “drift.” The term “drift” means allowing the various effectors in crystallization conditions to change in an uncontrolled manner until crystallization takes place or such a length of time passes that one gives up on that set of static conditions. For example, in a currently available hanging drop method concentration of protein in the drop is allowed to equilibrate with the reservoir solution so that the concentration of the protein in the drop increases at an uncontrolled rate till the crystals appear in the drop. In conventional systems “static conditions” followed by “drift” as described above are employed to test for each successful crystallization condition.
The term “dynamic open-loop condition” is defined wherein an effector is set to vary at a controlled rate and the rate is pre-set. For example one might set the pH to be varied by 0.05 pH units per second or set the protein concentration to increase by 0.5 mg/ml per second.
To apply dynamic open-loop conditions, one must be able to control effector levels with a useful precision that is preferably better than 30% of the full scale variation and most preferably better than 10% of the full scale variation and do so over a useful rate that is preferably over minutes and most preferably over seconds.
The term “dynamic closed-loop condition” is defined by an effector being set to be varied from an initial setting in response to a program that takes into account real time observations of the crystallization process. In one example the protein concentration is set to increase at 0.5 mg/ml per second until a crystal is observed to start forming and after that time the protein concentration is held fixed. In another example the NaCl concentration is set to increase at a rate of 100 mM/sec until a crystal is observed to initiate and then the NaCl concentration is reduced by 10 mM/sec until the crystallization process is completed. By changing an effector in response to the development of the first crystal one may avoid the formation of multiple crystals.
To apply dynamic closed-loop conditions, one must be able to control effector levels with a useful precision that is preferably better than 30% of the full scale variation and most preferably better than 10% of the full scale variation and do so over a useful rate that is preferably over minutes and most preferably over seconds. One must also be able to observe the process of crystallization or the state of the crystallization solution in real time in order to make controlled changes in the target effector levels in response to those observations.
The ability to use either open or closed loop dynamic conditions for crystallization is particularly significant because the quality and number of crystals formed is strongly sensitive to the dynamics of the crystal formation process.
In the most general type of conditions for crystallization wherein some set of effectors are to be set, some of those effectors may be static conditions, some may be open-loop dynamic conditions and some may be closed-loop dynamic conditions. The rates of change set for the effectors subject to open-loop dynamic conditions may be the same or they may be different. The rates of change and the response program for effectors subject to closed-loop dynamic conditions may be the same or they may be different. Certain methods of effector change such as evaporation are only suited for changing all molecular concentrations in the test solution simultaneously and at the same rate. Microdialysis and microfiltration can be used to change the concentrations of different molecules at different rates.
The “response time” of a system for changing effector levels is the minimum time required to change an effector and have it equilibrate through the solution. For this purpose working with smaller volumes reduces response time of any system. In particular the current invention associated with dynamically changing effector levels in nanoliter scale volumes is preferred over those using larger volumes.
The term crystallization “condition space for a set of effectors” means all the possible ways to set those effectors in experiments to test for crystallization. This includes using static, open-loop dynamic and closed-loop dynamic settings. The condition space for a set of effectors that includes the open-loop dynamic and closed-loop dynamic options is larger than the condition space for that set of effectors without those options.
The present invention discloses a fluid handling system for producing crystals of new biomolecules or new crystal forms of previously crystallized biomolecules.
The term “useful in structural determination” refers to crystals that can be harvested from the crystallization trial and subjected to x-ray crystallography. The methods of the present invention allow for testing of many sets of crystallization conditions and, unlike the methods currently available in the art, allow for removal of crystals from the microfluidic chip to be used in x-ray crystallographic structural determination.
a and 1b illustrate a microfabricated fluid handling system 10 according to the teachings of the present invention. The fluid handling system 10 includes a pin assembly, generically designated as assembly 10A, that includes at least a pair of pins sized and configured to hold a droplet of fluid between the tips of the pins. Specifically, the pin assembly comprises a first pin 11 and a second pin 12, which are connected to a holder 13. The pin tips 11a and 12a are separated by an initial separation distance D (
To acquire a droplet of a liquid sample, such as a protein solution containing a protein to be crystallized, the pin tips 11a, 12a are immersed in a reservoir containing a supply of a selected liquid sample. The pin tips 11a, 12a are positioned to allow capillary flow into a sample acquisition region 14. The capillary force induced in the sample acquisition region 14 pulls a droplet, having a volume defined by the separation distance and shape of the pin tips 11a, 11b, into the sample acquisition region 14. The capillary force produced between the surfaces of the pin tips holds the droplet in the sample acquisition region 14 formed between the two pin tips 11a, 11b. As shown in
a and 2b illustrate another embodiment of the fluid handling system according to the teachings of the present invention. The illustrated fluid handling system 10′ is illustrated in a sample acquisition mode for acquiring a droplet of a liquid sample having a predetermined volume from a reservoir containing a supply of the liquid sample. Like parts are designated with the same reference numerals. The fluid handling system 10′ of
To acquire a droplet of a liquid sample, such as a protein solution containing a protein to be crystallized, the pin tips 11a, 12a are immersed in a reservoir 17 containing a supply of a selected liquid sample. The pin tips 11a, 12a are positioned to allow capillary flow into to sample acquisition region 14. The capillary force induced in the sample acquisition region 14 pulls a droplet 18, having a volume defined by the separation distance of the pin tips 11a, 11b, into the sample acquisition region 14. The capillary force produced between the surfaces of the pin tips holds the droplet in the sample acquisition region 14 formed between the two pin tips 11a, 11b. The actuators 15 in the pins 11, 12 move the pins to vary the separation distance D between the tips, thereby varying the amount of sample that is acquired by the two-pin fluid handling system, or to handle the sample therefrom.
According to one practice, the fluid handling system of the invention is configured to handle (e.g., acquire) liquid samples in volumes between about 0.1 nanoliters and about 50 nanoliters. One skilled in the art will recognize that the acquired volume is not limited to this range and that the pins may be spaced apart to accommodate any suitable volume of liquid.
The actuators 15 can also compensate for varying physical properties of the particular liquid sample, such as viscosity, surface tension, and the like, by modifying the separation distance D between the pins. The sensors 16 may also be utilized to measure the force applied between the tips and the physical properties of the acquired liquid sample on the fly. In this manner, the settings (i.e. the pin separation distance) of the pin fluid handling system 10′ can be modified to compensate for variations in the measured properties of the liquid sample in real time.
According to the illustrative embodiment, the fluid handling systems 10, 10′ and/or pin assemblies 10A are fabricated from a silicon wafer using a microfabrication technique, such as a standard photolithography etching process, to fabricate the pin structures. One skilled in the art will recognize that alternative materials and manufacturing techniques may be utilized. For example, the fluid handling system may be made out of glass, plastic or any other suitable material. According to one embodiment, an array of fluid handling systems 10, each comprising two pins forming a channel therebetween, may be formed on a single substrate, such as a silicon wafer. For example, an array of up to about 300 or more systems 10 may be formed on a four-inch silicon wafer.
The use of the two-pin fluid handling system of the illustrated embodiment in spotting applications provides enhanced control over the size of the deposited spots in a microarray, and also allows for smaller spots to be formed and deposited.
The fluid handling system may further be utilized as a wet deposit system with dilution to dilute a selected volume of a first liquid in a second liquid sample.
One skilled in the art will recognize that any suitable means for controlling the temperature of the liquid carried by the pin of the fluid system may be utilized according to the teachings of the invention.
According to another embodiment of the invention, the temperature-controlled fluid handling system 10 may further include a temperature control circuit, shown in
The sensor 510 may comprise a thin film resistor, formed of conductive metals, carbon, a semi-conductor or any suitable material. The sensor is preferably integrated with the temperature-controlled fluid system and continuously measures the operating temperature of the system 10. One skilled in the art will recognize that any suitable temperature sensor and controller may be utilized in order to actively control the temperature of the fluid handling system.
As set forth, the device 10 of an illustrative embodiment of the invention comprises a picoliter—nanoliter silicon pipette suitable for acquiring and handling small volumes of liquid sample. According to one application, the temperature-controlled two-pin system 10 may be used as a crystallization device to form crystals from a protein or other biomolecule. The crystallization device can be programmed to automatically and very precisely pickup nanoliter amounts of a biomolecule sample to promote crystallization of a molecule in the biomolecule sample. As shown, in this application the pins 11, 12 form micro and picoscale crystallization cavities for crystallization purposes. By using these specially designed crystallization cavity devices, experiments can be done using nanogram quantities of protein or other biomolecule, a reduction in consumption of material by at least two orders of magnitude over conventional methods. By using automation designed around crystallization cavity devices, it is possible to simplify the crystallization process, create higher quality crystals and develop more reproducible processes for crystallization while reducing reagent consumption.
The crystallization process includes three stages: nucleation, crystal growth and cessation of crystal growth. During nucleation, an initial cluster of molecules associate in repeating units in three dimensions to form a thermodynamically stable aggregate. Crystals form in supersaturated solutions in which the protein concentration exceeds a nucleation concentration. Crystal growth ceases when the protein solution is sufficiently depleted of protein molecules or when other conditions change to modify the nucleation concentration. Proteins are generally induced to crystallize by adding agents that either alter their surface chargers or perturb the interactions between the protein and bulk solvent water to promote associations that lead to crystallization.
According to one embodiment, the two-pin system 10 may be used to grow protein crystals by mixing the protein to be crystallized with the crystallizing agents and adding the protein solution to a well. Initially, the protein concentration is less than the nucleation concentration. The crystallization conditions may be set in the well by exchanging dialyzable effectors, such as ions, water, small molecules, buffer, pH, ligands or other dialyzable effectors of crystallization, and/or altering the temperature of the protein solution. After setting the crystallization conditions by setting effectors in the well containing the protein solution, the two-pin device 10 may be used to pick up a nanoliter volume of the protein solution in the space between the tips 11a, 12a. Preferably, the volume of acquired protein solution is between about 0.1 and about 50 nanoliters. Next, the protein is concentrated by transpiration of water to or from the protein solution between the tips 11a, 12a to promote crystal formation. Transpiration may be controlled by controlling the temperature, humidity, the volume of the space 14 between the tips and/or shape of the region between the tips. As a result of the controlled transpiration, and resulting increase in the protein concentration, a crystal forms and is held between the pin tips 11a, 12a.
One skilled in the art will recognize that the crystallization device may also be used to crystallize other biomolecules or to co-crystallize combinations of biomolecules in a similar process to that described above.
The formation of the crystal may be observed in situ without requiring transfer of the formed crystal from the device 10. Because the tips 11a, 12a are open to the transmission of light and the sample acquisition region 14 is an open, rather than closed, cavity, the formation of the crystal may be observed using optical means. According to one embodiment, polarized light optics and CCD camera may be used to detect presence of crystals, though other suitable observation means may also be used. The ability to observe the formation process and the resulting crystal in situ allows for real time dynamic control of the crystallization conditions. Initialization of crystal formation may be observed and that observation may be used in real time to change or stabilize the protein crystallization conditions. For example, crystal formation may be observed and the temperature of the tips may be altered in real time using the temperature control element 200 to optimize crystal growth. Alternatively, the humidity may be altered in response to the observation. The crystal may be frozen and observed at intermediate points during the protein crystallization process to monitor and record the crystallization process. The crystal may also be observed at intermediate points during the protein crystallization process and that observation used to choose the best moment to freeze the droplet containing the crystal in the crystallization cavity structure 14.
After formation of the crystal, or, alternatively, during an intermediate point in the crystallization process, the crystal may be frozen in place without requiring transfer of the crystal from the device 10 wherein the crystal is formed. For example, after observation shows the crystal to be large enough (for example for x-ray diffraction studies at high resolution), the crystal may be frozen in place by changing the temperature of the pins using the temperature control element 200. Alternatively, the crystal or crystallizing sample may be frozen by moving the pins 11, 12 and dipping the pins 11, 12 into a cold solution, such as liquid propane or liquid nitrogen, to freeze the crystal.
Once a crystal is frozen in the pin structure, the whole device 10 and crystal complex formed therein is suitable for transport to and use in a high energy x-ray diffraction apparatus. The open pickup structures (i.e., the pins 11, 12) provides a path for x-rays to transmit into and through the crystal to the x-ray detectors.
The shape and size of the protein crystallization device 10 are specifically designed to control the rate of transpiration (i.e. evaporation), a key factor in obtaining quality crystals. According to one embodiment, the shape of the tips 11a, 12a is optimized to promote crystallization.
As an example of change in the rate of mass loss for different shapes,
The shape of the tips 11a, 12a may also be optimized for x-ray diffraction and for optical monitoring of the sample held between the tips.
According to another embodiment, the tips 11a, 12a may be coated in a hydrophobic, hydrophilic or other suitable material to promote the crystallization process.
As shown in
g is a cross-sectional view of the tips 11a, 12a according to an alternate embodiment. According to the alternate embodiment, the tip surfaces 70′ are curved to hold form a cylindrical or conical sample acquisition region 14 therebetween.
As shown in
According to an alternate embodiment, the solution in the array of wells 901 may have varied concentrations. The concentration in the wells 30 may be varied by setting effectors, such as adding or subtracting solvents, ions, detergents, drugs, ligands, or through other suitable means. The wells may include a membrane to retain proteins while altering the concentration of the protein solution by dialysis.
The automated, flexible evaporation-controlled crystal growth system of the present invention allows for several evaporation profiles to be explored simultaneously. The invention may thus provide dynamic and real-time control of protein concentration level via control of rate of water evaporation. Smaller populations of higher quality crystals can be produced, by choosing correct evaporation profile of crystallization material.
In one embodiment, the crystals of the present invention are a family of crystals that are different space groups, e.g., geometries, symmetries, or unit cells, of the same polypeptides and nucleic acids. The present invention allows a skilled artisan to sample many more conditions, with much less protein and in a much shorter time period, than conventional techniques. These improvements make it more likely that different crystal forms of the same protein will be identified. Accordingly, the invention, at least in part, is a family of structures containing 3, 4, 5, 6, 7, 8, 9, 10, 15, 20 or 25 members that are related by the fact that they all contain the same non-solvent molecules, e.g., proteins, nucleic acids, cofactors, or substrates.
Protein crystals can be stressed and even damaged during harvesting and/or subsequent manipulations and therefore become unsuitable for data collection. The present device avoids damage by being able to grow and freeze the crystals in the crystallization cavities formed between the pin tips 11, 12.
For proteins for which solubility varies with temperature, it is advantageous to use precision temperature control as a straightforward method of controlling protein concentration.
The protein crystallization device of the present invention combines a method and device to control the evaporation of solvent from crystallization material for protein crystallization. The protein crystallization device provides significant advantages over currently used fiber loops. For example, crystals can be grown, frozen and diffraction data can be collected in the pins, without requiring extra steps for crystal handling, which typically cause considerable crystal loss.
The protein crystallization device of the present invention provides significant advantages over prior methods for crystallizing proteins and other biomolecules. The operation in microscale levels substantially reduces or eliminates convection and sedimentation due to the small size of the drop and because surface tension is the major force acting on the droplet. The crystallization device 10 is reusable, precise and provides quick, accurate and reversible temperature control. The crystallization device 10 is easier to use than prior flexible fiber loop. The crystallization device is cost effective while providing accurate and improved control of nanoliter to picoliter volumes.
The ability to optically monitor the sample acquisition region between the tips 11, 12 of the fluid handling system has additional applications in addition to protein or biomolecule crystallization. According to other embodiments, optical monitoring of a sample between the tips 11, 12 in the two-pin liquid handling system 10 may be performed for any chemical or biochemical process for which experimental measurement of optimal conditions or response to variation of conditions is desirable.
The illustrated pins 41 and 42 can also include a relaxation region 51 for preventing breakage of the tips. One skilled in the art will recognize that the relaxation region 51 may be formed in one or both of the pins 41, 42 of the fluid handling system 40.
The illustrated fluid handling system 40 is formed from a silicon wafer using a standard photolithography etching process to fabricate one or more of the pin assembly including pins 41, 42, the relaxation region 51, the driver 44, and the fixed point 45 of the fulcrum region 46 in the wafer substrate 43. According to the illustrative embodiment, the fluid handling system 40 is fabricated from a silicon wafer having dimensions of about one square centimeter. The pins 41,42 have a length of about five millimeters, though one skilled in the art will recognize that the invention is not limited to this size. According to an alternate embodiment, a larger silicon wafer or other suitable substrate is provided, and an array of two-pin fluid handling systems is fabricated on the larger silicon wafer. For example, a silicon wafer having a size of about ten square centimeters may be used to fabricate an array of about seventy two-pin fluid handling systems 40 thereon. A fifteen square centimeter silicon wafer can be utilized to fabricate over one hundred two-pin fluid handling systems 40 in the silicon wafer substrate. Those of ordinary skill will readily recognize that any suitable configuration can be employed to move one or both of the pins.
According to an alternate embodiment of the invention, the fulcrum region can optionally include one or more bending sensors, illustrated as piezoresistors 62, on the left and right side of the fulcrum region to allow differential sensing of actual bending of the pin 42 in the fulcrum region. In this manner, the amount of bending, and the resultant tip separation distance may be controlled using a closed loop feedback system. The use of bending sensors further limits nonlinear temperature effects by allowing real-time sensing of tip displacement.
According to the illustrative embodiment, the driver 44 has an initial length L of four millimeters. A thirty-degree rise in temperature of the silicon results in a 1.08 micrometer expansion of the driver 44. The expansion of the driver 44 forces the pin 42 to rotate about the fixed pivot point 45, thereby increasing the separation distance between the tips 41a, 42a by greater than 108 microns.
According to the illustrative embodiment, a temperature control element can be coupled or affixed to the driver 44. For example, a heating element, such as a heating resistor 49, can be optionally coupled or affixed to the driver for applying heat thereto. The heating resistors may comprise poly resistors, diffused resistors or any suitable means for applying heat to the driver 44 in order to effect controlled expansion of the driver 44 and to vary the separation distance between the tips 41a, 42a. Optionally, cooling fins (not shown) are provided in the driver 44 near the fulcrum region 45 to prevent unwanted heating of the driver in the fulcrum region. According to an alternate embodiment, a temperature sensor (not shown) in communication with the heating means is included in the fluid handling system 40 to provide closed loop control of the driver 44 temperature.
One skilled in the art will recognize that the fluid handling system is not limited to the illustrative driver. According to alternate embodiments the driver 44 comprises an electrostatic system, a piezoelectric system, an electromechanical system, a thermoelectric actuator or any suitable system for applying a predetermined and defined force to cause controlled adjustment of the separation distance between the pin tips 41a, 42a. One skilled in the art will further recognize that the fluid handling system is not limited to a fulcrum for varying the separation distance and that any suitable mechanism for varying the separation distance may be utilized.
According to alternate embodiment, the one or both of the tip surfaces 70 and/or the outside shaft surface are coated with a hydrophilic, hydrophobic or other chemical coating to enhance droplet acquisition, handling and dispensing. For example, the tips 41, 42 may be formed of or coated with a hydrophilic coating to enhance retention of a sample in the sample acquisition region. According to one embodiment, the outside shaft surfaces of the tips 41,42 are coated with gold or another suitable hydrophobic material without affecting the tip surfaces 70 defining the sample acquisition region 14. The use of a metal coating provides enhanced control over the volume and release of a droplet. The use of silicon and/or gold additionally allows for more vigorous cleaning solutions to be utilized when cleaning the tips without degrading the system. In this manner, contamination of the tips is reduced.
The coating may be applied in a pattern to the tip surfaces 70 or the other surfaces of the tips 41, 42 by shadow masking. The coating may be sputtered, or evaporated on a surface in a predetermined pattern, defined by a mask. One skilled in the art will recognize that any suitable pattern for directing the liquid sample and enhancing control over sample acquisition, handling and dispensing may be utilized.
According to another embodiment, the fluid handling system may comprise a single pin having a suitable pattern coating applied to the surfaces of the pin tip. For example, the shaft of the single pin may be coated with a suitable hydrophobic coating and the tip of the pin may be coated with a suitable hydrophilic coating to enhance acquisition, manipulation and dispensing of a liquid sample.
According to an alternate embodiment, the spring 52 includes sensors to measure of the force of contact between the tip and a surface. For example, differential piezoresistive sensors may be included in the spring 52 and connected to an actuator (not shown) to control the spring using feedback control loop. The spring sensor may also be utilized to measure the force exerted by the droplet on the tips, and allow the driver to compensate for variable forces exerted by the droplet on the tips.
According to an alternate embodiment of the present invention, a relaxation region may be implemented in a two-pin fluid handling system comprising a pair of spaced-apart, fixed pins defining a sample acquisition region of fixed volume.
As discussed, the fluid handling system 10 or 40 of the illustrative embodiment may be microfabricated from a suitable substrate, such as silicon, glass or plastic. According to the illustrative embodiment, photolithography may be utilized to form the pin structures in the substrate. In photolithography, the pattern of the two pins and other components of the two-pin fluid handling system 10 or 40 are imprinted on a silicon wafer, or other substrate, using one or more photoresist layers that are patterned by UV or other light projected through one or more photo-masks containing the pattern on it. The substrate is then etched to fabricate the two-pin structure. One skilled in the art will recognize that any suitable microfabrication technique may be utilized to manufacture the two-pin fluid handling system of the illustrative embodiment of the present invention.
One skilled in the art will recognize that the described microfabrication technique may further be utilized to fabricate single-pin fluid handling systems from a silicon wafer or other suitable substrate. For example, it is within the scope of the invention to microfabricate a single-pin structure having two tips forming a sample channel for acquiring, manipulating and dispensing a liquid sample, as described in U.S. Pat. No. 6,101,946, from a silicon wafer by etching the silicon wafer to define the pin and sample channel.
One skilled in the art will recognize that the described invention in biomolecule crystallization may be implemented with any capillary uptake structure. For example it is within the scope of the invention to pick up the biomolecule solution with a single pin with a slot or in a cavity defined by the tips of three or more pins or in a cylindrical capillary.
The fluid handling system provides significant improvements to the process of forming, manipulating and dispensing droplets of samples for spotting and dilution applications. The illustrative configuration provides precise control over the amount of liquid sample that is acquired and deposited through the use of two pins having a variable separation distance. Adjusting the separation distance between the pin tips easily and precisely modifies the volume of the acquired liquid droplet and the deposited liquid droplet. Furthermore, measurements of the physical properties of the liquid volume can be made on the fly and the tip separation can be modified quickly and easily to compensate for variations. The use of sensors provides precise control of the tip separation distance to optimize the process of acquiring, manipulating and dispensing droplets of a liquid sample.
The present invention has been described relative to an illustrative embodiment. Since certain changes may be made in the above constructions without departing from the scope of the invention, it is intended that all matter contained in the above description or shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense.
It is also to be understood that the following claims are to cover all generic and specific features of the invention described herein, and all statements of the scope of the invention which, as a matter of language, might be said to fall therebetween.
Having described the invention, what is claimed as new and protected by Letters Patent is:
The present application claims priority to U.S. provisional patent application Ser. No. 60/427,423, filed Nov. 19, 2002, and U.S. provisional patent application Ser. No. 60/372,562, and is a continuation-in-part of U.S. Pat. application Ser. No. 10/027,171, filed Dec. 21, 2001 now U.S. Pat. No. 7,041,257. The present application is further related to patent application 10/328,931, entitled “Microfluidic Chip for Biomolecule Crystallization,” filed on even date herewith. The contents of each of the foregoing patent applications are expressly incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3885440 | Rossfelder | May 1975 | A |
3984307 | Kamentsky et al. | Oct 1976 | A |
4116069 | Lezgintsev et al. | Sep 1978 | A |
4175662 | Zold | Nov 1979 | A |
4659677 | Glover et al. | Apr 1987 | A |
4756427 | Gohde et al. | Jul 1988 | A |
5096676 | McPherson et al. | Mar 1992 | A |
5256241 | Noever | Oct 1993 | A |
5260030 | DeVaughn | Nov 1993 | A |
5271795 | Ataka et al. | Dec 1993 | A |
5552127 | Asano | Sep 1996 | A |
5643540 | Carter et al. | Jul 1997 | A |
5716852 | Yager et al. | Feb 1998 | A |
5741554 | Tisone | Apr 1998 | A |
5770151 | Roach et al. | Jun 1998 | A |
5807522 | Brown et al. | Sep 1998 | A |
5837200 | Diessel et al. | Nov 1998 | A |
5932100 | Yager et al. | Aug 1999 | A |
5957167 | Feygin | Sep 1999 | A |
5961934 | Arnowitz et al. | Oct 1999 | A |
5962329 | Ershov et al. | Oct 1999 | A |
5997636 | Gamarnik et al. | Dec 1999 | A |
6001231 | Kopf-Sill | Dec 1999 | A |
6024925 | Little et al. | Feb 2000 | A |
6039804 | Kim et al. | Mar 2000 | A |
6086825 | Sundberg et al. | Jul 2000 | A |
6101946 | Martinsky | Aug 2000 | A |
6110426 | Shalon et al. | Aug 2000 | A |
6174365 | Sanjoh | Jan 2001 | B1 |
6245297 | Kowallis | Jun 2001 | B1 |
6255119 | Baier | Jul 2001 | B1 |
6258331 | Sanjoh | Jul 2001 | B1 |
6269846 | Overbeck et al. | Aug 2001 | B1 |
6287872 | Schurenberg et al. | Sep 2001 | B1 |
6296673 | Santarsiero et al. | Oct 2001 | B1 |
6296702 | Bryning et al. | Oct 2001 | B1 |
6303387 | Birch et al. | Oct 2001 | B1 |
6309891 | Shalon et al. | Oct 2001 | B1 |
6319315 | Sanjoh | Nov 2001 | B1 |
6350617 | Hindsgaul et al. | Feb 2002 | B1 |
6365349 | Moynihan et al. | Apr 2002 | B1 |
6387330 | Bova et al. | May 2002 | B1 |
6406903 | Bray et al. | Jun 2002 | B1 |
6409832 | Weigl et al. | Jun 2002 | B1 |
6413586 | Vann et al. | Jul 2002 | B1 |
6417007 | Gittleman et al. | Jul 2002 | B1 |
6461572 | Calfee et al. | Oct 2002 | B1 |
6468346 | Arnowitz et al. | Oct 2002 | B1 |
6637473 | Ganz et al. | Oct 2003 | B1 |
6692972 | Yershov et al. | Feb 2004 | B1 |
6875402 | Hirota et al. | Apr 2005 | B1 |
6878553 | Li et al. | Apr 2005 | B1 |
20010005545 | Andou et al. | Jun 2001 | A1 |
20010049149 | Kennedy et al. | Dec 2001 | A1 |
20030148539 | van Dam et al. | Aug 2003 | A1 |
20030166263 | Haushalter et al. | Sep 2003 | A1 |
20040014042 | Ju | Jan 2004 | A1 |
20040142460 | Cima et al. | Jul 2004 | A1 |
20050019950 | Gierde et al. | Jan 2005 | A1 |
20050079621 | Elmes et al. | Apr 2005 | A1 |
20050112774 | Gilbert et al. | May 2005 | A1 |
20050164326 | Figeys et al. | Jul 2005 | A1 |
Number | Date | Country |
---|---|---|
19843655 | Mar 2000 | DE |
WO-03000422 | Jan 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20030170146 A1 | Sep 2003 | US |
Number | Date | Country | |
---|---|---|---|
60427423 | Nov 2002 | US | |
60372562 | Apr 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10027171 | Dec 2001 | US |
Child | 10328932 | US |